Department of Dermatology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
J Ocul Pharmacol Ther. 2011 Feb;27(1):83-92. doi: 10.1089/jop.2010.0084. Epub 2011 Jan 25.
To study the clinical features and to identify the molecules responsible for contact-allergic reactions following ocular use of corticosteroid (CS) preparations.
Observational case series.
We reviewed the clinical data, the patch test results, and sensitization sources in patients with a CS contact allergy, who have been patch tested in the K.U. Leuven Dermatology department during an 18-year period.
Eighteen subjects (out of 315 with CS delayed-type hypersensitivity) presented with allergic manifestations (conjunctivitis, eczema of the face, periocular skin or eyelids) of delayed-type hypersensitivity reactions to the use of CS-containing ocular preparations. The most common allergen was hydrocortisone, but most patients presented with multiple positive tests, not only to other CSs, but also to other active principles, preservatives, and vehicle components.
Ophthalmic CSs, despite their anti-inflammatory and antiallergic properties, may produce contact-allergic reactions.
研究眼部皮质类固醇(CS)制剂使用后发生接触过敏反应的临床特征,并鉴定相关致敏分子。
观察性病例系列研究。
我们回顾性分析了在 18 年间于鲁汶大学皮肤科行斑贴试验且对 CS 迟发型超敏反应阳性的患者的临床数据、斑贴试验结果和致敏源。
18 例患者(315 例 CS 迟发型超敏反应患者中的 18 例)出现了眼部 CS 制剂使用后迟发型超敏反应的过敏表现(结膜炎、面部湿疹、眼周皮肤或眼睑湿疹)。最常见的过敏原是氢化可的松,但大多数患者的斑贴试验结果呈阳性,不仅对其他 CS,而且对其他活性成分、防腐剂和赋形剂也呈阳性。
尽管眼部 CS 具有抗炎和抗过敏特性,但仍可能引发接触过敏反应。